We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Alliance Develops Tests for Food-Borne Pathogens

By Labmedica staff writers
Posted on 01 Jul 2003
Five new lateral flow rapid tests for food-borne pathogens have been jointly developed by BBInternational (BBI, Cardiff, UK) and the Analytics & Reagents Division of Merck KgaA (Darmstadt, Germany).

The five tests developed are for E Coli 0157, Salmonella, Campylobacter, Listeria, and Verotoxin type 1 and 2. More...
The tests allow detection in less than 20 minutes and can reliably guarantee the absence of the five important pathogens. Lateral flow tests are becoming more popular, because they provide a quick and reliable diagnosis. The new tests are based on BBI's expertise in lateral flow development and the production of premium gold colloid.

Merck identified the tests needed and then sought a technology platform that could produce them, finding one at BBI, which provides new-product development services for companies with limited lateral flow experience.

"It is an ideal choice for those who want to fully outsource the development of a new rapid test, including reagent development, without losing the ownership of how the test is developed and marketed,” said Julian Barnes, managing director of BBI. "Merck KgaA and BBI have worked together consistently over the last year and have developed five tests that both teams can be proud of.”


Related Links:
BBI
Merck

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Multi-Chamber Washer-Disinfector
WD 390
New
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Allevion Medical receives FDA Clearance for Vantage, introducing a fully disposable approach to minimally invasive spinal decompression (photo courtesy of Allevion Medical)

Single-Use System Enables Minimally Invasive Decompression for Lumbar Spinal Stenosis

Lumbar spinal stenosis is frequently driven by hypertrophic bone that narrows the canal and produces pain. Conventional decompression often relies on larger incisions and bulky retractors, adding time,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.